Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer
Jordi Codony-Servat, Xabier Garcia-Albeniz, Carles Pericay, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Rosa Gallego, Anna Martínez-Cardús, Eva Martinez-Balibrea, Joan MaurelVolume:
30
Language:
english
DOI:
10.1007/s12032-012-0428-0
Date:
March, 2013
File:
PDF, 420 KB
english, 2013